Day: July 22, 2024

Nokia and Bharti Airtel complete successful 5G NSA Cloud RAN trial in India

Written by Customer Service on July 22, 2024. Posted in Public Companies.

Press Release Nokia and Bharti Airtel complete successful 5G NSA Cloud RAN trial in IndiaFirst 5G NSA Cloud RAN trial adds to Nokia’s multiple 5G Cloud RAN references. Significant milestone in Airtel’s network evolution, diversifying portfolio in building scalable networks with agility and highly automated processes. Nokia’s anyRAN approach allows operators to evolve their networks to a hybrid RAN environment with both Cloud RAN and purpose-built RAN deployments co-existing delivering a high-quality performance.22 July 2024 Espoo, Finland – Nokia today announced that it has successfully completed its first 5G non-standalone (NSA) Cloud RAN trial with Bharti Airtel (Airtel) in India. The project supports Airtel’s strategy of delivering a superior customer experience using high-performing networks. It is expected to deliver higher...

Organizations report a four-fold increase in the deployment of generative AI since 2023

Written by Customer Service on July 22, 2024. Posted in Public Companies.

Press contact:Mollie MellowsTel: + 44 7342 709384mollie.mellows@capgemini.com Organizations report a four-fold increase in the deployment of generative AI since 2023 The vast majority (80%) have increased their year-on-year investment in generative AI Three quarters agree it is helping drive revenue and innovation Almost all organizations (97%) allow employees to use generative AI in some capacityParis, July 22, 2024 – Organizations are rapidly embracing generative AI, spurred by an uptick in investment and the value of this transformative technology. It has permeated across sectors and various functions within organizations, driving a shift in operations and business models. That’s according to the Capgemini Research Institute’s latest report, “Harnessing the value of generative AI 2nd edition: Use cases across sectors,” which...

Refresco announces acquisition of Frías, a leading Spanish manufacturer of plant-based drinks

Written by Customer Service on July 22, 2024. Posted in Mergers And Acquisitions.

Press Release Refresco announces acquisition of Frías, a leading Spanish manufacturer of plant-based drinks Rotterdam, The Netherlands, July 22, 2024 – Refresco, the global independent beverage solutions provider for retailers and global, national, and emerging (GNE) brands in Europe, North America, and Australia, today announces it has entered into an agreement to acquire Frías Nutrición (“Frías”) from Alantra Private Equity and the founding family. This transaction is subject to regulatory approval. Frías is a leading manufacturer of plant-based drinks with a production facility located in Burgos, Spain and employs around 250 people. Frías produces private label plant-based drinks, including almond, rice, hazelnut, and soy drinks, for key Spanish retailers and beyond. CEO Refresco, Hans Roelofs, commented: “As part of our proven...

Cornish Metals Announces Sale of Mactung and Cantung Royalties

Written by Customer Service on July 22, 2024. Posted in Mergers And Acquisitions.

VANCOUVER, British Columbia, July 22, 2024 (GLOBE NEWSWIRE) — Cornish Metals Inc. (AIM/TSX-V: CUSN) (“Cornish Metals” or the “Company”), a mineral exploration and development company focused on advancing its 100% owned and permitted South Crofty tin project in Cornwall, United Kingdom, is pleased to announce that it has entered into a binding agreement (the “Agreement”) with Elemental Altus Royalties Corp. (“Elemental Altus”) for the sale of the royalty interests that the Company holds on the Mactung and Cantung tungsten projects located in Northern Canada (together, the “Royalties”) for a total cash consideration of US$4,500,000 (the “Transaction”). Ken Armstrong, Interim CEO and Director of Cornish Metals, stated: “The sale of the Mactung and Cantung royalties follows Cornish Metals’ recently announced sale of the Nickel King...

Invitation – Ascom Half-Year Results Conference 2024

Written by Customer Service on July 22, 2024. Posted in Public Companies.

Ladies and Gentlemen, We cordially invite you to the online Half-Year Results Conference 2024 of Ascom Holding AG. There are two ways to participate in our conference:A conference call will be set up where analysts and media representatives can ask questions after the presentation.In addition, a live audio webcast with synchronized presentation slides including Q&A will be available. Date: Tuesday 6 August 2024 Starting Time: 10:00 a.m. CET Dial In: Link Conference Call Webcast: Link Live Audio Webcast Note: If you have any questions, please dial into the conference call just before the end of the webcast. To ask questions, press *14. An operator will greet you and invite you to ask your questions. Ascom will publish the press release, the presentation, and the Half-Year Report 2024 on August 6, 2024, at 06:30 a.m. CEST on...

Corbion reports the progress of its € 20 million share buyback program 15 July – 19 July 2024

Written by Customer Service on July 22, 2024. Posted in Public Companies.

Corbion hereby reports the transaction details related to its € 20 million share buyback program announced on 26 April 2024. During the week of 15 July up to and including 19 July 2024 a total of 44,266 shares were repurchased at an average price of € 19.8448 for a total amount of € 878,450.93. To date, the total consideration for shares repurchased amounts to € 19,765,545.55 representing 98.83% of the overall share buyback program. Corbion publishes on a weekly basis every Monday, an overview of the progress of the share buyback program on its website: https://www.corbion.com/Investor-relations/shareholder-information This overview contains detailed information on the daily amount of repurchased shares and individual share purchase transactions.AttachmentWeekly progress on Corbion share buyback program 15 July – 19 July...

Addex’s Partner Discontinues ADX71149 development in Epilepsy

Written by Customer Service on July 22, 2024. Posted in Public Companies.

Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 22, 2024 – Addex Therapeutics (SIX and Nasdaq: ADXN), a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders, announced today that its partner Janssen Pharmaceuticals, Inc. (now known as J&J Innovative Medicine) has informed the company that it has discontinued development of ADX71149 (JNJ-40411813) in epilepsy. The partnership between the two companies remains ongoing while the full data set from the Phase 2 study of ADX71149 (JNJ-40411813) as an adjunctive epilepsy treatment is analyzed. The decision follows top-line Phase 2 data announced on April 29, 2024, showing that adjunctive ADX71149 (JNJ-40411813) administration in patients with focal onset seizures with...

CEPI Expands Partnership with Valneva with a $41.3 Million Grant to Support Broader Access to the World’s First Chikungunya Vaccine

Written by Customer Service on July 22, 2024. Posted in Public Companies.

Valneva to receive up to $41.3 million from CEPI and the European Union to expand access to chikungunya vaccine, IXCHIQ® Funding will support clinical trials in vulnerable groups, such as children and pregnant women Partnership will also support technology transfer to an additional manufacturer to supply IXCHIQ® to Asian LMICs IXCHIQ® is already approved for use in adults 18 years of age and older in the U.S., Canada and EuropeOslo, Norway, and Saint-Herblain, France, July 22, 2024—The Coalition for Epidemic Preparedness Innovations (CEPI) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, have expanded their partnership to support broader access to the world’s first chikungunya vaccine, IXCHIQ®, in Low- and Middle-Income countries (LMICs), as well as post-marketing trials and potential label extensions...

Master Agreement on E/E Architecture Technical Collaboration With Volkswagen Group

Written by Customer Service on July 22, 2024. Posted in Public Companies.

XPENG and the Volkswagen Group will jointly develop industry-leading E/E Architecture for all locally produced vehicles based on Volkswagen’s China Main Platform (CMP) and Modular Electric Drive Matrix (MEB) platform The first vehicle equipped with the jointly developed E/E Architecture will SOP (Start of Production) within approximately 24 months Both parties will actively explore further collaboration opportunities to expand the scope of the usage of the jointly developed E/E ArchitectureGUANGZHOU, China, July 22, 2024 (GLOBE NEWSWIRE) — XPeng Inc. (the “Company” or “XPENG”) and the Volkswagen Group are pleased to announce today that, further to XPENG’s announcement dated April 17, 2024 (the “Announcement”) in connection with the framework agreement on technical collaboration with respect to electrical/electronic architecture...

Patient Enrollment Commenced in Pivotal Phase 3 Trial of Rexlemestrocel-L for Chronic Low Back Pain

Written by Customer Service on July 22, 2024. Posted in Public Companies.

NEW YORK, July 21, 2024 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, announced today that the confirmatory Phase 3 trial of its allogeneic, immunoselected, and industrially manufactured stromal cell product rexlemestrocel-L in patients with chronic low back pain (CLBP) due to inflammatory degenerative disc disease of less than five years duration has commenced enrollment at multiple sites across the United States. The United States Food and Drug Administration (FDA) has previously confirmed alignment with Mesoblast on the design of the 300-patient randomized, placebo-controlled trial and the 12-month primary endpoint of pain reduction as an approvable indication. Key secondary measures include improvement in quality of life, function, and...

Day: July 22, 2024

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals